Taro Pharmaceutical Industries Ltd. (TARO) Earnings
|
Expand Research on TARO
| Next EPS Date | 5/21/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -1.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/26/15  |
 |
Q415 | $0.00 | N/A | N/A | $244.2M | $881.79M | N/A |  | | Details |
| 11/3/15 |
|
Q216 | $3.11 | N/A | N/A | $212.1M | $250.8M | N/A | | | Details |
| 2/10/16 |
|
Q316 | $4.41 | N/A | N/A | $258.3M | $237.7M | N/A | | | Details |
| 2/7/18 | |
Q317 | $1.37 | N/A | N/A | $155.5M | $220.4M | = | | | Details |
| 8/10/16 |
Q116 | $2.59 | N/A | N/A | $233.8M | $215.3M | N/A | | | Details | |
| 2/10/15 | Q315 | $3.33 | N/A | N/A | $237.7M | $213.6M | N/A | | | Details | |
| 11/8/16 |
Q216 | $3.00 | N/A | N/A | $228.8M | $212.06M | N/A | | | Details | |
| 5/22/19 |
|
Q418 | N/A | $0.00 | N/A | N/A | $189.92M | N/A | N/A | N/A |
